Endurant Capital Management LP increased its stake in shares of AmerisourceBergen (NYSE:ABC) by 63.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 55,240 shares of the company’s stock after acquiring an additional 21,500 shares during the period. AmerisourceBergen comprises about 1.6% of Endurant Capital Management LP’s portfolio, making the stock its 26th largest position. Endurant Capital Management LP’s holdings in AmerisourceBergen were worth $5,072,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently modified their holdings of the stock. BlackRock Inc. raised its holdings in shares of AmerisourceBergen by 5.8% during the fourth quarter. BlackRock Inc. now owns 12,384,803 shares of the company’s stock worth $1,137,171,000 after acquiring an additional 679,417 shares during the period. Vulcan Value Partners LLC raised its holdings in shares of AmerisourceBergen by 29.4% during the fourth quarter. Vulcan Value Partners LLC now owns 7,530,523 shares of the company’s stock worth $691,452,000 after acquiring an additional 1,710,816 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of AmerisourceBergen by 107.3% during the third quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock worth $434,385,000 after acquiring an additional 2,776,287 shares during the period. Wells Fargo & Company MN raised its holdings in shares of AmerisourceBergen by 11.4% during the third quarter. Wells Fargo & Company MN now owns 3,726,377 shares of the company’s stock worth $308,358,000 after acquiring an additional 381,936 shares during the period. Finally, Harding Loevner LP raised its holdings in shares of AmerisourceBergen by 89.6% during the third quarter. Harding Loevner LP now owns 3,166,794 shares of the company’s stock worth $134,939,000 after acquiring an additional 1,496,761 shares during the period. Institutional investors and hedge funds own 67.30% of the company’s stock.
In other news, insider Peyton R. Howell sold 3,000 shares of AmerisourceBergen stock in a transaction dated Wednesday, March 7th. The shares were sold at an average price of $93.78, for a total value of $281,340.00. Following the completion of the transaction, the insider now owns 49,189 shares of the company’s stock, valued at approximately $4,612,944.42. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Tim G. Guttman sold 11,600 shares of AmerisourceBergen stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $93.40, for a total transaction of $1,083,440.00. The disclosure for this sale can be found here. In the last three months, insiders sold 156,809 shares of company stock valued at $14,988,589. Insiders own 27.30% of the company’s stock.
A number of equities research analysts recently commented on ABC shares. Needham & Company LLC raised their price objective on shares of AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a report on Wednesday, November 22nd. Robert W. Baird set a $99.00 price objective on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Friday, December 1st. Deutsche Bank started coverage on shares of AmerisourceBergen in a report on Monday, December 4th. They set a “buy” rating and a $97.00 price objective on the stock. Cowen set a $107.00 price objective on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, December 12th. Finally, Goldman Sachs upgraded shares of AmerisourceBergen from a “neutral” rating to a “buy” rating in a report on Friday, December 15th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. AmerisourceBergen has a consensus rating of “Buy” and a consensus price target of $103.34.
AmerisourceBergen stock opened at $96.61 on Monday. The firm has a market cap of $21,222.22, a price-to-earnings ratio of 20.82, a P/E/G ratio of 1.44 and a beta of 1.03. AmerisourceBergen has a 12-month low of $71.90 and a 12-month high of $106.27. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.95 and a quick ratio of 0.50.
AmerisourceBergen (NYSE:ABC) last released its earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The business had revenue of $40.47 billion during the quarter, compared to the consensus estimate of $40.42 billion. During the same quarter last year, the firm earned $1.36 earnings per share. The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. equities analysts forecast that AmerisourceBergen will post 6.58 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 5th. Stockholders of record on Tuesday, February 20th were given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date of this dividend was Friday, February 16th. AmerisourceBergen’s dividend payout ratio (DPR) is presently 32.76%.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.